Journal News

JBC: How bacteria build efficient photosynthesis machines

Laurel Oldach
Aug. 1, 2019

Researchers facing a future world with a larger human population and more uncertain climate are looking to photosynthetic bacteria for engineering solutions to improve crop yields.

In the Journal of Biological Chemistry, a Canadian research team reports on how cyanobacteria finesse one of the most wasteful steps in photosynthesis. The study investigated the assembly of carboxysomes in which the bacteria concentrate carbon dioxide, boosting the efficiency of a critical enzyme called RuBisCO.

“Essentially everything we eat starts with RuBisCO,” said Matthew Kimber, a professor at the University of Guelph in Ontario and senior author on the paper.

The enzyme, which is made of 16 protein subunits, is essential for photosynthesis. Using energy captured from light, it incorporates carbon dioxide into organic molecules from which a plant then builds new sugar. Unfortunately, it’s not terribly efficient. Or, from Kimber’s point of view, “RuBisCO has a really thankless task.”

The enzyme evolved in an ancient world where carbon dioxide was common and oxygen was rare. As a result, it isn’t very picky in discriminating between the two gases. Now that the atmospheric tables have turned, RuBisCO often accidentally captures oxygen, generating a useless compound that the plant then has to recycle.

CcmM (orange) binds to RubisCO holoenzymes (yellow and green)
Matthew Kimber
This colorful illustration shows how CcmM (orange) binds to RubisCO holoenzymes (yellow and green) without dislodging a yellow subunit. By crosslinking multiple enzymes, CcmM forms the basis of the carboxysome.

Cyanobacteria make few such mistakes, because bacteria collect their RuBisCO into dense bodies known as carboxysomes. The bacteria pump bicarbonate (simply hydrated CO2) into the cell; once it gets into the carboxysome, enzymes convert the bicarbonate into carbon dioxide. Because the carbon dioxide can’t escape through the protein shell surrounding the carboxysome, it builds up to high concentrations, helping RuBisCO avoid costly mistakes.

Kimber wants to understand the logic of carboxysomes’ organization. “They’re actually phenomenally intricate machines,” he said. “The cyanobacterium makes 11 or so normal-looking proteins, and these somehow organize themselves into this self-regulating mega-complex that can exceed the size of a small cell.”

One of carboxysomes’ most impressive tricks is self-assembly, which Kimber’s lab set out to understand. They looked at a protein, CcmM, that corrals RuBisCO enzymes into new carboxysomes. They knew that part of CcmM looks a lot like a subunit of RuBisCO — so much so that researchers suspect ancient cyanobacteria created CcmM by duplicating a RuBisCO gene.

Most scientists in the field believed that CcmM binds to the enzyme by usurping that RuBisCO subunit’s spot. But when Kimber’s lab took a detailed look at CcmM’s structure and binding, the results showed that was wrong. True, CcmM was similar in shape to the small RuBisCO subunit. But the complexes it formed still included all eight small subunits, meaning that instead of stealing a spot from a RuBisCO subunit, CcmM had to be binding elsewhere.

“This is very odd from a biological perspective, because if CcmM arose by duplicating the small subunit, it almost certainly originally bound in the same way,” Kimber said. “At some point, it must have evolved to prefer a new binding site.”

The researchers also found that a linker between binding domains in CcmM is short enough that “instead of wrapping around RuBisCO, it tethers (individual enzymes) together like beads on a string,” Kimber said. “With several such linkers binding each RuBisCO at random, it crosslinks everything into this big glob; you wrap a shell around it, and this then becomes the carboxysome.”

Scientists at another university reported last fall that they had succeeded in making tobacco plants with a stripped-down carboxysome in their chloroplasts. Those plants didn’t grow especially well, and the authors concluded that they had taken away too many components of the carboxysome; although it could be built in the chloroplast, it was a drag on the plants instead of a help.

A better understanding of how proteins like CcmM contribute to carboxysome construction and function could help bioengineers leverage carboxysome efficiency in the next generation of engineered plants.

Enjoy reading ASBMB Today?

Become a member to receive the print edition monthly and the digital edition weekly.

Learn more
Laurel Oldach

Laurel Oldach is a former science writer for the ASBMB.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

The quest to treat and cure xerostomia
Interview

The quest to treat and cure xerostomia

July 23, 2024

Blake Warner, chief of the Salivary Disorders Unit at the NIH talks about his lab’s efforts to develop treatments for dry mouth.

There's more to blue cheese than just the stench
News

There's more to blue cheese than just the stench

July 21, 2024

Virginia Tech researchers discovered a way to synthesize a compound in the mold of blue cheese that has antibacterial and anticancer properties.

Engineering cells to broadcast their behavior can help scientists study their inner workings
News

Engineering cells to broadcast their behavior can help scientists study their inner workings

July 20, 2024

Researchers can use waves to transmit signals from the invisible processes and dynamics underlying how cells make decisions.

From the journals: JBC
Journal News

From the journals: JBC

July 19, 2024

Lung cancer cells resist ferroptosis. ORMDL3 in ulcerative colitis. Novel genetic variants in thyroid cancer. Read about these recent papers.

Seeking the sweet spot to beat a pig parasite
Journal News

Seeking the sweet spot to beat a pig parasite

July 16, 2024

Researchers extracted, separated and tested glycans from the porcine whipworm in an effort to determine the best way to develop treatments and vaccines.

Radioactive drugs strike cancer with precision
News

Radioactive drugs strike cancer with precision

July 14, 2024

The tumor-seeking radiopharmaceuticals are charting a new course in oncology, with promise for targeted treatments with fewer side effects.